查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1811026

2025年性行为感染传染病（STD）自我检测全球市场报告

Sexually Transmitted Disease (STD) Self-Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年性行为感染传染病 (STD) 自我检测市场将强劲成长，到 2029 年将达到 22.1 亿美元，年复合成长率（CAGR）为 9.8%。预测期内的增长可归因于性行为感染患病率的上升、人们对私密便捷的检测方法的偏好日益增长、自我检测套组中数字健康功能的日益集成、发展中地区家庭诊断的广泛普及以及先进自我检测技术的监管机构的批准日益增多。预计这一时期的主要趋势包括快速分子诊断工具的进步、用于结果追踪的行动应用程式整合的增强、可检测多种感染疾病的自我检测套组的创建、谨慎包装和交付解决方案的创新以及人工智慧主导的测试结果分析的进步。

梅毒病例的增加促进了性行为感染传染病 (STD) 自我检测市场的成长。梅毒是一种性传染感染疾病，如果不及时治疗，会导致溃疡和严重的健康併发症。梅毒感染的增加主要是由于保险套使用率下降，尤其是在高风险性行为族群。性传染病自我检测为个人提供了一种个人化、便捷的居家检测方法，有助于早期诊断。早期发现可及时治疗，降低併发症风险并有助于防止感染扩散。例如，根据美国疾病管制与预防中心 (CDC) 的数据，2023 年报告了约 209,253 例梅毒病例，比 2022 年报告的 207,269 例增加了 1%。这种流行率的成长推动了对自我检测解决方案的需求。

性传染病自我检测市场的新兴市场正在开发创新产品，例如非处方 (OTC) 样本采集试剂套件，以帮助早期诊断和治疗。这些 OTC套件允许个人在家中无需处方笺即可采集尿液或拭子等样本，从而提供一种谨慎且易于使用的感染疾病识别方法。 2023 年 8 月，美国数位健康公司 iHealth Labs Inc. 推出了 HIV 和梅毒检测的 CheckMeSafe 家用采集套件。这款经 FDA 批准的试剂套件可让 18 岁及以上的个人在家中采集血液样本以检测 HIV（I 型、II 型和 P24 抗原）和梅毒。可以使用预付费隔夜送货标籤将检体邮寄到检测实验室，最快两天即可获得保密结果。该套件提供高度准确的结果，对 HIV 的敏感性为 99.9%，对梅毒的敏感性为 99.5%。所有测试均在 CLIA 认证和 CAP 认可的实验室进行，并符合联邦和州品质法规。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球性行为感染传染病（STD）自我检测：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球性行为感染传染病（STD）自我检测市场：成长率分析
  • 全球性行为感染传染病（STD）自我检测市场表现：规模与成长，2019-2024
  • 全球性行为感染传染病 (STD) 自我检测市场预测：规模与成长，2024-2029 年，2034 年
  • 全球性行为感染传染病（STD）自我检测：总潜在市场（TAM）

第六章 市场细分

  • 全球性行为感染传染病（STD）自我检测市场（按样本类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 血液检查
  • 尿液检查
  • 口试
  • 全球性行为感染传染病（STD）自我检测市场（按分销管道、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 医院药房
  • 网路药局
  • 零售药局
  • 全球性行为感染传染病（STD）自我检测市场的应用、表现及预测，2019-2024年、2024-2029年、2034年
  • 披衣菌感染披衣菌 (CT) 或淋病奈瑟菌 (NG) 检测
  • 梅毒检测
  • 人类免疫力缺乏病毒（HIV）检测
  • 其他的
  • 全球性行为感染传染病（STD）自我检测市场：血液检测细分、类型、表现及预测，2019-2024年、2024-2029年、2034年
  • 指尖采血样本
  • 干血斑（DBS）样本
  • 微血管采血装置
  • 全球性行为感染传染病（STD）自我检测市场：尿液检查细分、类型、表现及预测，2019-2024年、2024-2029年、2034年
  • 首次采集尿液样本
  • 中段尿液样本
  • 添加防腐剂的尿液收集
  • 全球性行为感染传染病（STD）自我检测市场：口腔测试细分、类型、表现及预测，2019-2024年、2024-2029年、2034年
  • 口腔拭子样本
  • 口腔液体收集装置
  • 牙龈拭子采集

第七章 区域和国家分析

  • 全球性行为感染传染病（STD）自我检测市场：按地区、绩效及预测，2019-2024年、2024-2029年、2034年
  • 全球性行为感染传染病（STD）自我检测市场：国家、绩效与预测，2019-2024年、2024-2029年、2034年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 性行为感染传染病（STD）自我检测市场：竞争格局
  • 性行为感染传染病（STD）自我检测市场：公司简介
    • Abbott Laboratories
    • Viatris Inc.
    • Hologic Inc.
    • OraSure Technologies Inc.
    • LifeCell International

第31章：其他领先和创新企业

  • LetsGetChecked Health Inc.
  • Visby Medical Inc.
  • Everlywell Inc.
  • Guangzhou Wondfo BIoTech Co. Ltd.
  • NOWDiagnostics Inc.
  • bioLytical Laboratories Inc.
  • Atomo Diagnostics Limited
  • myLAB Box Inc.
  • BioSure UK Ltd.
  • JAL Medical（S）Pte Ltd.
  • TBD Health Inc.
  • Recombigen Laboratories Private Limited
  • Alpine Biomedicals Pvt. Ltd.
  • Homed-IQ BV
  • Newfoundland Diagnostics Pvt. Ltd.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年性行为感染传染病（STD）自我检测市场：提供新机会的国家
  • 2029年性行为感染传染病（STD）自我检测市场：细分市场带来新机会
  • 2029年性行为感染传染病（STD）自我检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r37130

Sexually transmitted disease (STD) self-testing involves individuals collecting their own samples to screen for STDs without visiting a clinical facility. This approach offers a private, convenient, and prompt way to detect infections such as chlamydia, gonorrhea, HIV, and syphilis through at-home kits or mail-in laboratory services.

The primary types of STD self-testing samples include blood-based, urine-based, and oral-based tests. Blood-based self-tests typically use a small blood sample from a finger prick to effectively identify infections like HIV, syphilis, and hepatitis in their early stages. These tests are distributed through various channels, including hospital pharmacies, online pharmacies, and retail pharmacies, and are used for multiple purposes such as chlamydia trachomatis (CT) or Neisseria gonorrhoeae (NG) detection, syphilis screening, HIV testing, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The sexually transmitted disease (STD) self-testing market research report is one of a series of new reports from The Business Research Company that provides sexually transmitted disease (STD) self-testing market statistics, including the sexually transmitted disease (STD) self-testing industry global market size, regional shares, competitors with the sexually transmitted disease (STD) self-testing market share, detailed sexually transmitted disease (STD) self-testing market segments, market trends, opportunities, and any further data you may need to thrive in the sexually transmitted disease (STD) self-testing industry. This sexually transmitted disease (STD) self-testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The sexually transmitted disease (STD) self-testing market size has grown rapidly in recent years. It will grow from $1.38 billion in 2024 to $1.52 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth during the historical period can be linked to greater awareness of sexual health, increased adoption of home-based healthcare options, the expansion of government-supported STD screening programs, wider accessibility of over-the-counter self-testing kits, and growing concerns over privacy associated with clinic-based testing.

The sexually transmitted disease (STD) self-testing market size is expected to see strong growth in the next few years. It will grow to $2.21 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The anticipated growth in the forecast period can be attributed to the rising prevalence of sexually transmitted infections, increasing preference for private and convenient testing methods, greater integration of digital health features in self-testing kits, broader availability of at-home diagnostics in developing regions, and growing regulatory approval of advanced self-testing technologies. Key trends expected during this period include progress in rapid molecular diagnostic tools, enhanced mobile app integration for tracking results, the creation of self-test kits that detect multiple infections, innovations in discreet packaging and delivery solutions, and advancements in AI-driven analysis of test outcomes.

The increasing number of syphilis cases is contributing to the growth of the sexually transmitted disease (STD) self-testing market. Syphilis is a sexually transmitted infection that causes sores and can result in severe health complications if untreated. The rise in syphilis infections is largely attributed to a decline in consistent condom use, especially among individuals involved in high-risk sexual behavior. STD self-testing offers a private and convenient method for individuals to screen themselves at home, encouraging early diagnosis. Early detection leads to timely treatment, reducing the risk of complications and helping prevent the spread of infection. For example, according to the Centers for Disease Control and Prevention (CDC), approximately 209,253 syphilis cases were reported in the United States in 2023, a 1% increase from the 207,269 cases reported in 2022. This growing prevalence is boosting the demand for self-testing solutions.

Companies in the STD self-testing market are developing innovative products like over-the-counter (OTC) sample collection kits to support early diagnosis and treatment. These OTC kits allow individuals to collect samples such as urine or swabs at home without a prescription, offering a discreet and user-friendly way to identify infections. In August 2023, iHealth Labs Inc., a US-based digital health company, introduced the CheckMeSafe home collection kit for HIV and syphilis testing. This FDA-approved kit enables individuals aged 18 and older to collect blood samples from home for testing HIV (types I, II, P24 antigen) and syphilis. Samples can be mailed to a laboratory using a prepaid overnight shipping label, with confidential results available in as little as two days. The kit delivers highly accurate outcomes, with sensitivity levels of up to 99.9% for HIV and 99.5% for syphilis. All tests are processed in a CLIA-certified and CAP-accredited lab, ensuring they meet federal and state quality regulations.

In December 2024, OraSure Technologies Inc., a US-based company that offers point-of-need and home diagnostic tests, acquired Sherlock Biosciences for an undisclosed amount. This acquisition is intended to expand OraSure's presence in the at-home diagnostics market by incorporating Sherlock Biosciences' CRISPR-based molecular technology. The integration of this advanced technology aims to create rapid, over-the-counter self-tests for STDs such as chlamydia and gonorrhea. These tests are designed to provide lab-quality results at home within minutes, making accurate and private STD testing more accessible. Sherlock Biosciences is a US-based company engaged in clinical trials for rapid OTC diagnostics for sexually transmitted infections.

Major players in the sexually transmitted disease (std) self-testing market are Abbott Laboratories, Viatris Inc., Hologic Inc., OraSure Technologies Inc., LifeCell International, LetsGetChecked Health Inc., Visby Medical Inc., Everlywell Inc., Guangzhou Wondfo Biotech Co. Ltd., NOWDiagnostics Inc., bioLytical Laboratories Inc., Atomo Diagnostics Limited, myLAB Box Inc., BioSure UK Ltd., JAL Medical (S) Pte Ltd., TBD Health Inc., Recombigen Laboratories Private Limited, Alpine Biomedicals Pvt. Ltd., Homed-IQ B.V., Newfoundland Diagnostics Pvt. Ltd.

North America was the largest region in the sexually transmitted disease (STD) self-testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sexually transmitted disease (STD) self-testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sexually transmitted disease (STD) self-testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sexually transmitted disease (STD) self-testing market consists of revenues earned by entities by providing services such as telehealth consultations, digital result delivery, follow-up care coordination, and online pre-test counselling. The market value includes the value of related goods sold by the service provider or included within the service offering. The sexually transmitted disease (STD) self-testing market includes sales of sample collection devices, buffer solutions or reagents, at-home diagnostic kits, mobile app-based test tracking tools, and smartphone-compatible test devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sexually Transmitted Disease (STD) Self-Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sexually transmitted disease (std) self-testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sexually transmitted disease (std) self-testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sexually transmitted disease (std) self-testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Sample Type: Blood Based Test; Urine Based Test; Oral Based Test
  • 2) By Distribution Channel: Hospital Pharmacies; Online Pharmacies; Retail Pharmacies
  • 3) By Application: Chlamydia trachomatis (CT) Or Neisseria gonorrhoeae (NG) Testing; Syphilis Testing; Human Immunodeficiency Virus (HIV) Testing; Other Applications
  • Subsegments:
  • 1) By Blood-Based Test: Fingerstick Blood Sample; Dried Blood Spot (DBS) Sample; Capillary Blood Collection Device
  • 2) By Urine-Based Test: First-Catch Urine Sample; Midstream Urine Sample; Preservative-Added Urine Collection
  • 3) By Oral-Based Test: Oral Swab Sample; Oral Fluid Collection Device; Gumline Swab Collection
  • Companies Mentioned: Abbott Laboratories; Viatris Inc.; Hologic Inc.; OraSure Technologies Inc.; LifeCell International; LetsGetChecked Health Inc.; Visby Medical Inc.; Everlywell Inc.; Guangzhou Wondfo Biotech Co. Ltd.; NOWDiagnostics Inc.; bioLytical Laboratories Inc.; Atomo Diagnostics Limited; myLAB Box Inc.; BioSure UK Ltd.; JAL Medical (S) Pte Ltd.; TBD Health Inc.; Recombigen Laboratories Private Limited; Alpine Biomedicals Pvt. Ltd.; Homed-IQ B.V.; Newfoundland Diagnostics Pvt. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Sexually Transmitted Disease (STD) Self-Testing Market Characteristics

3. Sexually Transmitted Disease (STD) Self-Testing Market Trends And Strategies

4. Sexually Transmitted Disease (STD) Self-Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Sexually Transmitted Disease (STD) Self-Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Sexually Transmitted Disease (STD) Self-Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Sexually Transmitted Disease (STD) Self-Testing Market Growth Rate Analysis
  • 5.4. Global Sexually Transmitted Disease (STD) Self-Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Sexually Transmitted Disease (STD) Self-Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Sexually Transmitted Disease (STD) Self-Testing Total Addressable Market (TAM)

6. Sexually Transmitted Disease (STD) Self-Testing Market Segmentation

  • 6.1. Global Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Based Test
  • Urine Based Test
  • Oral Based Test
  • 6.2. Global Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • 6.3. Global Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chlamydia trachomatis (CT) Or Neisseria gonorrhoeae (NG) Testing
  • Syphilis Testing
  • Human Immunodeficiency Virus (HIV) Testing
  • Other Applications
  • 6.4. Global Sexually Transmitted Disease (STD) Self-Testing Market, Sub-Segmentation Of Blood-Based Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fingerstick Blood Sample
  • Dried Blood Spot (DBS) Sample
  • Capillary Blood Collection Device
  • 6.5. Global Sexually Transmitted Disease (STD) Self-Testing Market, Sub-Segmentation Of Urine-Based Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • First-Catch Urine Sample
  • Midstream Urine Sample
  • Preservative-Added Urine Collection
  • 6.6. Global Sexually Transmitted Disease (STD) Self-Testing Market, Sub-Segmentation Of Oral-Based Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral Swab Sample
  • Oral Fluid Collection Device
  • Gumline Swab Collection

7. Sexually Transmitted Disease (STD) Self-Testing Market Regional And Country Analysis

  • 7.1. Global Sexually Transmitted Disease (STD) Self-Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Sexually Transmitted Disease (STD) Self-Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sexually Transmitted Disease (STD) Self-Testing Market

  • 8.1. Asia-Pacific Sexually Transmitted Disease (STD) Self-Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sexually Transmitted Disease (STD) Self-Testing Market

  • 9.1. China Sexually Transmitted Disease (STD) Self-Testing Market Overview
  • 9.2. China Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sexually Transmitted Disease (STD) Self-Testing Market

  • 10.1. India Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sexually Transmitted Disease (STD) Self-Testing Market

  • 11.1. Japan Sexually Transmitted Disease (STD) Self-Testing Market Overview
  • 11.2. Japan Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sexually Transmitted Disease (STD) Self-Testing Market

  • 12.1. Australia Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sexually Transmitted Disease (STD) Self-Testing Market

  • 13.1. Indonesia Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sexually Transmitted Disease (STD) Self-Testing Market

  • 14.1. South Korea Sexually Transmitted Disease (STD) Self-Testing Market Overview
  • 14.2. South Korea Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sexually Transmitted Disease (STD) Self-Testing Market

  • 15.1. Western Europe Sexually Transmitted Disease (STD) Self-Testing Market Overview
  • 15.2. Western Europe Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sexually Transmitted Disease (STD) Self-Testing Market

  • 16.1. UK Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sexually Transmitted Disease (STD) Self-Testing Market

  • 17.1. Germany Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sexually Transmitted Disease (STD) Self-Testing Market

  • 18.1. France Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sexually Transmitted Disease (STD) Self-Testing Market

  • 19.1. Italy Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sexually Transmitted Disease (STD) Self-Testing Market

  • 20.1. Spain Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sexually Transmitted Disease (STD) Self-Testing Market

  • 21.1. Eastern Europe Sexually Transmitted Disease (STD) Self-Testing Market Overview
  • 21.2. Eastern Europe Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sexually Transmitted Disease (STD) Self-Testing Market

  • 22.1. Russia Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sexually Transmitted Disease (STD) Self-Testing Market

  • 23.1. North America Sexually Transmitted Disease (STD) Self-Testing Market Overview
  • 23.2. North America Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sexually Transmitted Disease (STD) Self-Testing Market

  • 24.1. USA Sexually Transmitted Disease (STD) Self-Testing Market Overview
  • 24.2. USA Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sexually Transmitted Disease (STD) Self-Testing Market

  • 25.1. Canada Sexually Transmitted Disease (STD) Self-Testing Market Overview
  • 25.2. Canada Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sexually Transmitted Disease (STD) Self-Testing Market

  • 26.1. South America Sexually Transmitted Disease (STD) Self-Testing Market Overview
  • 26.2. South America Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sexually Transmitted Disease (STD) Self-Testing Market

  • 27.1. Brazil Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sexually Transmitted Disease (STD) Self-Testing Market

  • 28.1. Middle East Sexually Transmitted Disease (STD) Self-Testing Market Overview
  • 28.2. Middle East Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sexually Transmitted Disease (STD) Self-Testing Market

  • 29.1. Africa Sexually Transmitted Disease (STD) Self-Testing Market Overview
  • 29.2. Africa Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Sexually Transmitted Disease (STD) Self-Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sexually Transmitted Disease (STD) Self-Testing Market Competitive Landscape And Company Profiles

  • 30.1. Sexually Transmitted Disease (STD) Self-Testing Market Competitive Landscape
  • 30.2. Sexually Transmitted Disease (STD) Self-Testing Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. OraSure Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. LifeCell International Overview, Products and Services, Strategy and Financial Analysis

31. Sexually Transmitted Disease (STD) Self-Testing Market Other Major And Innovative Companies

  • 31.1. LetsGetChecked Health Inc.
  • 31.2. Visby Medical Inc.
  • 31.3. Everlywell Inc.
  • 31.4. Guangzhou Wondfo Biotech Co. Ltd.
  • 31.5. NOWDiagnostics Inc.
  • 31.6. bioLytical Laboratories Inc.
  • 31.7. Atomo Diagnostics Limited
  • 31.8. myLAB Box Inc.
  • 31.9. BioSure UK Ltd.
  • 31.10. JAL Medical (S) Pte Ltd.
  • 31.11. TBD Health Inc.
  • 31.12. Recombigen Laboratories Private Limited
  • 31.13. Alpine Biomedicals Pvt. Ltd.
  • 31.14. Homed-IQ B.V.
  • 31.15. Newfoundland Diagnostics Pvt. Ltd.

32. Global Sexually Transmitted Disease (STD) Self-Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sexually Transmitted Disease (STD) Self-Testing Market

34. Recent Developments In The Sexually Transmitted Disease (STD) Self-Testing Market

35. Sexually Transmitted Disease (STD) Self-Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Sexually Transmitted Disease (STD) Self-Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Sexually Transmitted Disease (STD) Self-Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Sexually Transmitted Disease (STD) Self-Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer